Galderma Group AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	780	457	368
Cash & Short-Term Investments	780	457	368
Cash Growth	70.68%	24.19%	-
Accounts Receivable	1,044	892	750
Inventory	525	403	420
Other Current Assets	87	91	78
Total Current Assets	2,437	1,843	1,616
Net Property, Plant & Equipment	744	577	529
Other Intangible Assets	4,639	4,829	4,923
Goodwill	5,129	5,129	5,129
Long-Term Investments	3	1	10
Other Long-Term Assets	442	238	264
Total Assets	13,393	12,617	12,471
Accounts Payable	943	676	653
Accrued Expenses	912	705	654
Current Portion of Long-Term Debt	65	36	63
Other Current Liabilities	133	109	201
Total Current Liabilities	2,055	1,528	1,571
Long-Term Debt	2,689	2,723	4,846
Long-Term Leases	1	2	10
Other Long-Term Liabilities	499	574	675
Total Long-Term Liabilities	3,189	3,299	5,531
Total Liabilities	5,243	4,827	7,102
Common Stock	2,092	2,136	6,259
Treasury Stock	-378	-15	-
Additional Paid-in Capital	64	48	43
Accumulated Other Comprehensive Income	25	-55	-32
Retained Earnings	6,347	5,676	-901
Shareholders' Equity	8,149	7,790	5,369
Total Liabilities & Equity	13,393	12,617	-12,471
Total Debt	2,755	2,761	4,919
Net Cash (Debt)	-1,975	-2,304	-4,551
Net Cash Per Share	-8.33	-9.69	-19.16
Book Value	8,149	7,790	5,369
Book Value Per Share	34.38	32.76	22.60
Tangible Book Value	-1,619	-2,168	-4,683
Tangible Book Value Per Share	-6.83	-9.12	-19.71